JOAN MOORE: Open Payments
NPI 1821483231 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,805 in 66 payments from 17 companies in 2025. Trend: 2023 $2,616 · 2024 $2,528 · 2025 $1,805
Food & beverage: $1,805
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 2 | $316 |
| Abbott Laboratories | 10 | $295 |
| Boston Scientific Corporation | 8 | $273 |
| Novartis Pharmaceuticals Corporation | 15 | $236 |
| Merck Sharp & Dohme LLC | 7 | $135 |
| BridgeBio Pharma, Inc. | 4 | $125 |
| Novo Nordisk Inc | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
Products named: Barostim Neo System, WATCHMAN FLX, LEQVIO, CARDIOMEMS, Attruby, VERQUVO, Wegovy, JARDIANCE.
Industry payments across TX — which companies pay providers there.
